Clinical Laboratory Tests Market Trend, Marketing Channels and Investment Feasibility

Clinical Laboratory Tests Market Summary

The global clinical laboratory tests market size was estimated at USD 125.94 billion in 2024 and is projected to reach USD 213.04 billion by 2030, growing at a CAGR of 8.88% from 2025 to 2030. As global life expectancy rises, with most developed economies now witnessing averages exceeding 80 years, the demand for diagnostic testing continues to increase. This growth is largely due to the rising burden of chronic and lifestyle-related illnesses, as well as the growing emphasis on early disease detection, proactive health monitoring, and treatment optimization. Clinical laboratory testing supports improved health outcomes and is a core component of routine healthcare delivery.

A significant market driver is the high incidence of cardiovascular diseases and diabetes. The World Health Organization (WHO) reports that cardiovascular conditions, including heart disease and stroke, were responsible for roughly 17.9 million deaths globally in 2021, highlighting their substantial health impact. At the same time, the increasing prevalence of diabetes has widened the patient base requiring frequent laboratory testing to manage blood glucose levels and prevent complications. Factors such as changing dietary habits, rising obesity, limited physical activity, and the increased adoption of smoking contribute to cardiovascular disease growth. Moreover, the elevated risk of long-term cardiovascular complications associated with SARS-CoV-2 infections underscores the importance of laboratory diagnostics for timely risk evaluation and monitoring.

Key Market Trends & Insights

• North America clinical laboratory tests industry held the largest share of market in 2024, driven by strong healthcare infrastructure, high diagnostic awareness, and the presence of leading laboratory networks and technology developers.
• Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030 owing to ongoing investments in advanced testing technologies, precision medicine, and preventive care programs.
• By type, HbA1c testing segment held the largest market share at 12.39% in 2024, reflecting its importance in continuous diabetes management and the increasing adoption of these tests for monitoring long-term glycemic control.
• By end use, the central laboratories segment held the largest share of the market in 2024, supported by high-volume testing capabilities, advanced equipment integration, and strong operational efficiency.

Order a free sample PDF of the Clinical Laboratory Tests Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 125.94 Billion
• 2030 Projected Market Size: USD 213.04 Billion
• CAGR (2025-2030): 8.88%
• North America: Largest market in 2023

Key Companies & Market Share Insights

The clinical laboratory tests industry is driven by a mix of established leaders and emerging innovators, each employing distinct strategies to enhance their market footprint. Major players such as Quest Diagnostics Incorporated, Sonic Healthcare Limited, and Laboratory Corporation of America Holdings maintain dominance through continuous test innovations, acquisitions, and strategic partnerships aimed at expanding service offerings and reinforcing their global presence.

On the other hand, emerging participants like Clinical Reference Laboratory and Cinven are rapidly gaining traction by introducing novel, differentiated solutions. These companies are heavily focused on geographic expansion, customer acquisition, and strategic collaborations to strengthen their technological capabilities and market relevance. For example, Omega Laboratories, in December 2022, introduced Urine Drugs of Abuse testing services in Canada-an expansion complementing their existing molecular testing portfolio and underscoring the shift toward integrated, multi-modal diagnostics.

Across the industry, both key and emerging players are continually investing in the development and evolution of laboratory technologies. Their shared goal is to improve patient outcomes while boosting the overall effectiveness and efficiency of healthcare services.

Key Players

• Quest Diagnostics Incorporated
• Abbott
• Cinven
• Laboratory Corporation of America Holdings
• ARUP Laboratories
• OPKO Health, Inc.
• UNILABS
• Clinical Reference Laboratory, Inc.
• Synnovis Group LLP

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The clinical laboratory tests market is expected to continue expanding due to the rising prevalence of chronic diseases, increasing focus on preventive healthcare, and growth in routine health check-ups. The adoption of innovative testing solutions, including molecular diagnostics, automation, and digital health platforms, will significantly enhance testing speed, accuracy, and accessibility. Additionally, growing healthcare spending in both developed and emerging economies is likely to boost demand for early diagnosis and regular patient monitoring. With the shift toward personalized medicine and improved patient care standards, laboratory testing will remain essential in supporting informed clinical decisions, optimizing treatment pathways, and improving global public health outcomes.